IMMUNOVANT, INC. (IMVT) Operating cash flow 2019–2026
IMMUNOVANT, INC. (IMVT) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$407.3MFY2026 · since FY2019: -$28.5M → -$407.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2026 | -$407.3M | -8.4% |
| FY2025 | -$375.9M | -75.5% |
| FY2024 | -$214.2M | -13.8% |
| FY2023 | -$188.2M | -77.4% |
| FY2022 | -$106.1M | -27.3% |
| FY2021 | -$83.3M | -56.2% |
| FY2020 | -$53.4M | -86.9% |
| FY2019 | -$28.5M | — |
Source: SEC XBRL filings · For reference only · Not investment advice